Publications

5891 Results

Southwest Oncology Group phase II study of irinotecan in patients with advanced transitional cell carcinoma of the urothelium [PMID18501081]

Authors
TM Beer;B Goldman;CR Nichols;DP Petrylak;M Agarwal;CW Ryan;ED Crawford
Journal / Conference
Clinical Genitourinary Cancer 6(1):36-39
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
S0306

Does the level of prostate cancer risk affect cancer prevention with finasteride?

Authors
IM Thompson;CM Tangen;HL Parnes;SM Lippman;CA Coltman Jr
Journal / Conference
Urology 71(5):854-857
Year
2008
Research Committee(s)
Cancer Control
PMID
PMID18455628
PMC
PMC2692669
Study Number(s)
SWOG-9217

Prostate-specific antigen progression (PSA-P) predicts overall survival (OS) in patients (pts) with metastatic prostate cancer (PC): data from S9346 and S9916.

Authors
B Goldman;M Hussain;C Tangen;C Higano;DP Petrylak;NJ Vogelzang;ED Crawford
Journal / Conference
Journal of Clinical Oncology 26(15s):253s, #5015
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346, S9916

S0124: A randomized phase III trial of cisplatin + irinotecan (PI) versus cisplatin + etoposide (PE) in 671 patients (pts) with extensive stage small cell lung cancer (E-SCLC)

Authors
RB Natale;PN Lara;K Chansky;J. Crowley;JR Jett;JE Carleton;JP Kuebler;H Lenz;P Mack;DR Gandara
Journal / Conference
Journal of Clinical Oncology 26(15S):400s, #7512
Year
2008
Research Committee(s)
Lung
Study Number(s)
S0124

SWOG 0222: A phase II study of tirapazamine (NSC-130181, TPZ)/cisplatin/etoposide (PE) and concurrent thoracic radiotherapy (TRT) for limited stage small cell lung cancer (LSCLC)

Authors
QT Le;J Moon;M Redman;S Williamson;P Lara;Z Goldberg;LE Gaspar;J Crowley;D Moore;DR Gandara
Journal / Conference
Journal of Clinical Oncology 26(15S):402s, #7523
Year
2008
Research Committee(s)
Lung
Study Number(s)
S0222

Encouraging survival with erlotinib in advanced papillary renal cell carcinoma (pRCC): final results from Southwest Oncology Group study 0317.

Authors
C Pan;M Hussey;P Lara;P Mack;R Nagle;J Dutcher;W Samlowski;J Clark;M Gordon;E Crawford
Journal / Conference
Journal of Clinical Oncology 26(15S):262s, #5051
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
S0317

SWOG0345: phase II trial of imatinib in dermatofibro-sarcoma protuberans (DFSP)

Authors
SM Schuetze;CJ Rankin;BP Rubin;JE Butrynski;A Lazar;EC Borden
Journal / Conference
Journal of Clinical Oncology 26(15S):573s, #10580
Year
2008
Research Committee(s)
Sarcoma
Study Number(s)
S0345

Sorafenib in patients with platinum (plat) treated extensive stage small cell lung cancer (E-SCLC): a SWOG (S0435) phase II trial

Authors
BJ Gitlitz;BS Glisson;J Moon;HJ Reimers;DR Gandara
Journal / Conference
Journal of Clinical Oncology 26(15S):433s, #8039
Year
2008
Research Committee(s)
Lung
Study Number(s)
S0435

Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. [PMID18235113]

Authors
EL Korn;PY Liu;SJ Lee;JAW Chapman;D Niedzwiecki;VJ Suman;J Moon;VK Sondak;MB Atkins;EA Eisenhauer;W Parulekar;SN Markovic;S Saxman;JM Kirkwood
Journal / Conference
Journal of Clinical Oncology 26(4):527-534
Year
2008
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8118, SWOG-8240, SWOG-8324, SWOG-8562, SWOG-8569, SWOG-8723, SWOG-8754, SWOG-8804, SWOG-8913, SWOG-8921, SWOG-9116, SWOG-9223, SWOG-9228, SWOG-9348, SWOG-9350, SWOG-9505, S9622, S9804

Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment

Authors
Y Song;C Tangen;P Goodman;HL Parnes;MS Lucia;IM Thompson;AR Kristal
Journal / Conference
The Prostate 68:281-286
Year
2008
Research Committee(s)
Cancer Control
PMID
PMID18163420
Study Number(s)
SWOG-9217